Literature DB >> 14980080

Small ISGs coming forward.

Pia Møller Martensen1, Just Justesen.   

Abstract

Interferons (IFNs) were first characterized as antiviral proteins. Since then, IFNs have proved to be involved in malignant, angiogenic, inflammatory, immune, and fibrous diseases and, thus, possess a broad spectrum of pathophysiologic properties. IFNs activate a cascade of intracellular signaling pathways leading to upregulation of more than 1000 IFN-stimulated genes (ISGs) within the cell. The function of some of the IFN-induced proteins is well described, whereas that of many others remain poorly characterized. This review focuses on three families of small intracellular and intrinsically nonsecreted proteins (10-20 kDa) separated into groups according to their amino acid sequence similarity: the ISG12 group (6-16, ISG12, and ISG12-S), the 1-8 group (9-27/Leu13, 1-8U, and 1-8D), and the ISG15 group (ISG15/UCRP). These IFN-induced genes are abundantly and widely expressed and mainly induced by type I IFN. ISG15 is very well described and is a member of the ubiquitin-like group of proteins. 9-27/Leu-13 associates with CD81/TAPA-1 and plays a role in B cell development. The functions of 1-8U, 1-8D, 6-16, ISG12, and ISG12-S proteins are unknown at present.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14980080     DOI: 10.1089/107999004772719864

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  35 in total

1.  Modulation of gene expression in MHCC97 cells by interferon alpha.

Authors:  Wei-Zhong Wu; Hui-Chuan Sun; Lu Wang; Jie Chen; Kang-Da Liu; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

2.  Interferon-alpha response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment.

Authors:  Shi-He Guan; Mengji Lu; Petra Grünewald; Michael Roggendorf; Guido Gerken; Jörg F Schlaak
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

Review 3.  Viral defense, carcinogenesis and ISG15: novel roles for an old ISG.

Authors:  Ian F Pitha-Rowe; Paula M Pitha
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-03       Impact factor: 7.638

4.  Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.

Authors:  Hangfei Qi; Virginia Chu; Nicholas C Wu; Zugen Chen; Shawna Truong; Gurpreet Brar; Sheng-Yao Su; Yushen Du; Vaithilingaraja Arumugaswami; C Anders Olson; Shu-Hua Chen; Chung-Yen Lin; Ting-Ting Wu; Ren Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-03       Impact factor: 11.205

5.  Identification of the IFITM3 gene as an inhibitor of hepatitis C viral translation in a stable STAT1 cell line.

Authors:  L Yao; H Dong; H Zhu; D Nelson; C Liu; L Lambiase; X Li
Journal:  J Viral Hepat       Date:  2011-03-16       Impact factor: 3.728

6.  IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells.

Authors:  Chai Phei Gan; Kin Kit Sam; Pei San Yee; Nur Syafinaz Zainal; Bernard Kok Bang Lee; Zainal Ariff Abdul Rahman; Vyomesh Patel; Aik Choon Tan; Rosnah Binti Zain; Sok Ching Cheong
Journal:  Cell Oncol (Dordr)       Date:  2019-04-04       Impact factor: 6.730

7.  IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.

Authors:  Rui André Saraiva Raposo; Miguel de Mulder Rougvie; Dominic Paquin-Proulx; Phillip M Brailey; Vinicius D Cabido; Paul M Zdinak; Allison S Thomas; Szu-Han Huang; Greta A Beckerle; Richard B Jones; Douglas F Nixon
Journal:  JCI Insight       Date:  2017-01-12

8.  Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas.

Authors:  Mirjana Urosevic; Kazuyasu Fujii; Bastien Calmels; Elisabeth Laine; Nikita Kobert; Bruce Acres; Reinhard Dummer
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

9.  Suppression of interferon (IFN)-inducible genes and IFN-mediated functional responses in BCR-ABL-expressing cells.

Authors:  Efstratios Katsoulidis; Antonella Sassano; Beata Majchrzak-Kita; Nathalie Carayol; Patrick Yoon; Alison Jordan; Brian J Druker; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2008-02-20       Impact factor: 5.157

Review 10.  Antiviral activity of innate immune protein ISG15.

Authors:  Ronald N Harty; Paula M Pitha; Atsushi Okumura
Journal:  J Innate Immun       Date:  2009       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.